Why the study?
Does chronic intrarenal infusion of low-dose angiotensin II increase arterial pressure without impairing renal function in dogs?
Does chronic intrarenal infusion of low-dose angiotensin II increase arterial pressure without impairing renal function in dogs?
Chronic intrarenal infusion of low-dose angiotensin II in dogs increases systemic arterial pressure without impairing renal function.
Supports intrarenal AngII in canine hypertension without renal impairment; hypothesis-generating and leaves open human translation.
To determine whether chronic angiotensin II (AngII) infusion into the renal artery, at a dose which increases systemic arterial pressure, reduces glomerular filtration rate (GFR) and renal blood flow, AngII was infused at 0.5 ng/kg per min into the renal artery or intravenously in chronically instrumented dogs for 1 month. 2. Mean arterial pressure (MAP) rose significantly (P < 0.05) during the infusion of AngII into the renal artery (+7 +/- 2 mmHg on days 26-30). There were no significant changes in GFR or renal blood flow. When the same dose of AngII was infused intravenously, MAP did not change significantly (-2 +/- 2 mmHg) and there were no significant changes in GFR or in renal blood flow. 3. We conclude that AngII infused into the renal artery for 1 month, at a dose which was initially subpressor, causes a rise in arterial pressure that is not associated with impairment of renal function.
No takes yet. Share an insight, caveat, or question.
Stevenson et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: